Sangamo Therapeutics
SGMO
#10546
Rank
HK$0.24 B
Marketcap
HK$0.58
Share price
0.00%
Change (1 day)
-83.19%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -HK$0.87 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are HK$34.55 Million. In 2025 the company made an earning of -HK$0.85 Billion a decrease over its 2024 earnings that were of -HK$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.87 Billion1.67%
2025 -HK$0.85 Billion9.71%
2024 -HK$0.78 Billion-17.27%
2023 -HK$0.94 Billion-40.88%
2022 -HK$1.58 Billion9.79%
2021 -HK$1.44 Billion41.52%
2020 -HK$1.02 Billion23.17%
2019 -HK$0.83 Billion36.33%
2018 -HK$0.61 Billion36.89%
2017 -HK$0.45 Billion-22.32%
2016 -HK$0.57 Billion54.86%
2015 -HK$0.37 Billion75.62%
2014 -HK$0.21 Billion0.13%
2013 -HK$0.21 Billion
2011 -HK$0.29 Billion43.66%
2010 -HK$0.2 Billion28.52%
2009 -HK$0.16 Billion-23.55%
2008 -HK$0.2 Billion2.45%
2007 -HK$0.2 Billion19.5%
2006 -HK$0.17 Billion50.78%
2005 -HK$0.11 Billion75%
2004 -HK$61.64 Million-33.25%
2003 -HK$92.34 Million-62.27%
2002 -HK$0.25 Billion102.82%
2001 -HK$0.13 Billion23.21%
2000 -HK$97.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.82 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.29 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$12.73 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-HK$19.83 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$84.16 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.18 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.82 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA